Information Provided By: 
Fly News Breaks for July 29, 2019
ZBH
Jul 29, 2019 | 07:50 EDT
Jefferies analyst Raj Denhoy raised his price target for Zimmer Biomet to $167 from $150 following the company's better than expected Q2 results. Zimmer's "steadily improving outlook" is hard to ignore but the stock's valuation is not reflecting it, Denhoy tells investors in a research note. He keeps a Buy rating on the shares.
News For ZBH From the Last 2 Days
There are no results for your query ZBH
